N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) was a predictive marker of cardiovascular disease (CVD)-related death in chronic dialysis patients. NT-proBNP was also correlated with markers of inflammation, malnutrition and protein-energy wasting.

We hypothesized whether NT-proBNP was also associated with non-CVD death in chronic dialysis patients.

A prospective observational study for incidence of death in chronic dialysis patients was conducted.

Prevalent chronic dialysis patients (n = 1310) were enrolled and followed for 24 months.

One hundred forty-four deaths were recorded. Area under the curve using ROC analysis for NT-proBNP showed: all causes of death (0.761), CVD-related (0.750), infection and malignancy-related (0.702) and others and unknown (0.745).

After adjusting for age, sex, hemodialysis vintage, cardiothoracic ratio, mean pre-dialysis systolic blood pressure, dry weight and basal kidney disease, the hazard ratios (95% confidence intervals) per 1-log NT-proBNP calculated using multivariate Cox analysis were:

all causes of death, 3.83 (2.51-5.85); CVD-related, 4.30 (2.12-8.75); infection and malignancy-related, 2.41 (1.17-4.93); and others and unknown origin, 5.63 (2.57-12.37).

NT-proBNP was significantly associated not only with CVD-relate but also with non-CVD-related deaths in this population of prevalent chronic dialysis patients.

在慢性透析患者中，NT-proBNP(氨基端支持B型促尿钠排泄的肽)是一种与CVD(心血管疾病)相关死亡的预测标记。NT-proBNP也是与炎症、营养失调以及蛋白质能量浪费的标记相关联的。

我们假定，在慢性透析患者中，NT-proBNP是否也与非心血管疾病死亡有关联。

在慢性透析患者中，开展了一项对于死亡发生率的预测性观察研究。

一般的慢性透析患者被登记和跟踪24个月。

144个死亡个案被记录下来。

在曲线下的面积(译者注:原文此处应有图表)，对NT-proBNP使用ROC分析显示:所有的死亡原因(0.761)，相关的心血管疾病(0.750)，感染与相关的恶性肿瘤(0.704)以及其它和未知因素(0.745)。

在调整年龄，性别，血液透析，心脏胸廓系数后，意味着在透析收缩压前，干体重，基底肾脏疾病，使用多变量Cox分析的每1对估算的NT-proBNP风险比率(95%可靠区间)为:
所有死亡原因3.83(2.51-5.85)；相关CVD,4.30(2.12-8.75)；感染和恶性肿瘤2.41(1.17-4.93)；以及其它和未知来源，5.63(2.57-12.37)。

在普遍的透析患者中，NT-proBNP不仅与相关CVD有着显著的关联，而且也与普通慢性透析患者人群中非相关CVD死亡有着紧密的联系。

